Quick Answer

USDA has not issued a new veterinary-biologics packaging rule. However, its current modernization review explicitly includes packaging and labeling specifications. For vaccine bottle projects, buyers can reduce later rework by locking key packaging specifications before sample approval and commercial scale-up.

The U.S. Department of Agriculture is currently reviewing the regulatory framework for veterinary biologics under 9 CFR Parts 101–118 and 123–124. On September 25, 2026, USDA extended the public-comment period to November 2. The underlying review covers a broad range of veterinary biologics controls, including packaging and labeling specifications.

For animal-health companies, this does not mean packaging requirements have already changed. It does mean that packaging documentation should be treated as part of the product-control system rather than as a last-minute purchasing detail.

Six Packaging Specifications to Lock Before Sample Approval

1. Bottle capacity and target fill: Confirm nominal bottle capacity and the intended fill quantity. Do not assume that a bottle size alone defines the final fill configuration.

2. Neck and closure combination: Record the neck dimensions, rubber-stopper specification and aluminum-cap configuration as one controlled package system.

3. Sterilization requirement: Confirm whether the project requires a sterilized bottle and which sterilization route is compatible with the validated product and process.

4. Filling and capping line fit: Check bottle geometry, neck presentation and closure handling against the customer’s filling and capping equipment before commercial volume is released.

5. Printing and label area: Define where batch identification, product information or customer branding will be applied, and confirm that the available print/label area is suitable for the target market.

6. Controlled specification and change record: Keep the approved bottle, closure, sterilization state, printing and packing configuration under a documented specification so later changes can be reviewed before implementation.

How This Connects to FUDAPLASTIC Vaccine Bottles

FUDAPLASTIC’s published Vaccine Bottle range includes 10–500 mL options, multiple published neck dimensions, rubber-stopper and aluminum-cap configurations, sterilization options shown on the product page, printing support, samples and customization. These options can be used as a starting point for project screening, but the final package must be evaluated against the customer’s formulation, filling process, stability program and target-market requirements.

For U.S. veterinary biologics projects, FUDAPLASTIC should not claim that a package is “USDA-compliant” based only on container specifications. The practical role of the packaging supplier is to provide clear component specifications and samples so the veterinary biologics manufacturer can complete its own qualification and regulatory work.

FAQ

Has USDA already changed veterinary biologics packaging rules?

No. USDA is gathering public input for a broader modernization review. The September 25 notice only extended the comment period to November 2, 2026.

What should a vaccine bottle buyer send before requesting samples?

At minimum: target capacity and fill, required neck/closure system, sterilization requirement, filling/capping method, printing or label-area needs, estimated commercial volume and destination market.

Can a packaging supplier decide regulatory suitability?

No. The supplier can provide packaging specifications, samples and manufacturing information, while the veterinary biologics company remains responsible for product-specific compatibility, stability and regulatory qualification.